chrisvoncsefalvay/vaers-outcomes huggingface dataset:
03/31/2022, I had a sore throat. On 4/1/2022 I had the worse headache I have ever had. I had chills, fatigue and weak.  On 4/2/2022 I was congested and had brain fog. Congestion and brain fog continued to the present, 6 days. Tested positive positive for COVID on 4/1/2022. I was prescribed an antiviral by the doctor.
Patient's mother called stating that her son stated that he passed out after receiving the vaccination; none of the staff had witnessed the patient falling nor did the patient bring it to the attention of the staff while he was at our facility. Upon reviewing the cameras, it can be seen that the patient stumbles to his knees then immediately sits in the chair adjacent to the location of his stumble while the staff had turned and faced away from the waiting area, when staff had turned around the patient was already seated in the chair. The mother also stated that the patient had vomited at the residence. The mother was advised that the patient should seek medical attention since he had already left the facility. Upon follow-up with the patient, they did not seek medical attention but that the symptoms had resolved.
Case received vaccine at 10:30AM and at approximately 10 minutes into recovery stated he "feels a little dizzy" Case requested a drink of water. Vital signs stable at temp 97.6 Pulse 88 Respirations 16. Pulse ox 99% BP 128/70.  He denied any shortness of breath, chest pain, difficulty swallowing itching or scratchy throat.  He was advised to be observed for another 15 minutes and stated he was feeling better and returned to work at 11 AM At approximately 11:50 AM patient returned to clinic with boss stating he vomited in the rest room.  Patient taken to recover room cot was placed in supine position on cot vital signs continued to be stable with 97.6 88 16 120/70 He complained of funny feeling in his throat. He was give Benadryl Liquid 50mg PO and continued with stable vital signs 97.6  88  20 120/70. He continued to complain of the funny feeling in his throat he was given Epinephrine IM .5ml,  He did appear anxious and tearful after speaking with his friend on the cell phone.  Vital signs remained stable of 99% SAO2 Pulse 83 Respirations 22 BP 128/70.  Throughout entire event he was able to speak in clear sentences with the interpreter assistance.  Patient was advised to go to ED for further evaluation and observation. He consented and 911 was called. EMS arrived at approximately 12:30 PM and report was given to EMT on patient event at clinic along with written information on vaccine and vital signs.
nausea; bad headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), NAUSEA (nausea) and HEADACHE (bad headache) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006021A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Aug-2021, the patient experienced NAUSEA (nausea) and HEADACHE (bad headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with ACETYLSALICYLIC ACID, DIPHENHYDRAMINE CITRATE, PARACETAMOL (EXCEDRIN PM HEADACHE) for Headache, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) and NAUSEA (nausea) outcome was unknown and HEADACHE (bad headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported
I received the 1st dose of Moderna on 03/18/2021 012A21A, and a half dollar sized rash on the injection site. It was itching severely. I had to use ice pack, It was like poison ivy. Hydrocortisone cream helped it go away. On my 2nd dose about three days later I would wake up in the middle of night with congestion cough, and shortness of breath. This only occurred in the middle of the night. I called my doctor, because the cough was extreme with phlegm. My PCP had me do a rescue albuterol inhaler and had me use it with a canister. I used this for almost a month in a half a couple of times a week at night. I received my booster dose on 12/28/2021 LOT#013F21A. It was a week after and the same symptoms came back, but it wasn't as bad as the 2nd dose. I'm still waking up in the middle of the night with shortness of breath, I cough a little and I haven't used the inhaler going on at least two months. The third dose was nothing like the second dose. I am also concerned about my blood pressure, it has always been normal, but my blood work has shown that my cholesterol has went up about 20 points. I have noticed also there are days when I'm short of breath and I do not have the stamina as I used to. I feel weak on some days.
Arm is red in large patches (the size of the palm of my h and) above and below the injection site itself. Area is slightly raised and warm to the touch. Itches slightly.  Slightly painful to touch.  Redness was noticed Sunday morning (2/28), but may have been there Saturday night - I just wasn't attentive.  No treatment - unspecified Dr. office just asked that I report it, but not that I need to be seen  by a physician in person.
raised, red, pruritic lesions noted on face 8-10 hr p/vax;pt waited approx96hr to seek medical attention;no treatment;resolved 7-10 days later;
No adverse event; Patient administered a dose from the incorrect vial initially; This spontaneous case was reported by a health care professional and describes the occurrence of INCORRECT DOSE ADMINISTERED (Patient administered a dose from the incorrect vial initially) and NO ADVERSE EVENT (No adverse event) in a 5-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 215K22A) for COVID-19 prophylaxis.     The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 15-Jun-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .2 milliliter. On 15-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced INCORRECT DOSE ADMINISTERED (Patient administered a dose from the incorrect vial initially). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (Patient administered a dose from the incorrect vial initially) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INCORRECT DOSE ADMINISTERED (Patient administered a dose from the incorrect vial initially).    No concomitant medication was reported. It was reported that on 15-Jun-2023, the patient received a single dose of 0.2 mL from vial with the pink cap and the label with the yellow border. Not reported any symptoms and no additional doses have been administered at this time. No treatment medication was reported.
Began having heart palpitations, heart rate was 120 checked with pulse ox, has been ongoing off and on since vaccine
Headache; presented tightness of chest; bad taste in her mouth./she still has the taste in her mouth; she has acid reflux; she felt really dizzy; This is a spontaneous report from a contactable consumer (patient). A 66-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 15Apr2021 09:00 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On 15APR2021, the patient experienced headache, presented tightness of chest, bad taste in her mouth/she still has the taste in her mouth, she has acid reflux, she felt really dizzy. Caller states she wants to know if that is normal and if she can take the second one. The events were considered as non-serious. The outcome of the event bad taste in her mouth was not recovered and other events was recovered in Apr2021.
(L) upper arm (site of Dtap injection) is swollen, red, and warm to touch (painful); covering about 25% of upper arm.
exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a patient (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy) in a 34-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Chronic UTI (Improved recently) in 1990 and Pre-eclampsia (Sudden onset pre-eclampsia; no complications with infant). Concurrent medical conditions included Drug allergy (Sulfa medications) and Alcohol use (1 drink a week). Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for Pre-eclampsia, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.    On 13-Feb-2021 at 8:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 17-Jun-2020 and the estimated date of delivery was 30-Mar-2021. On 13-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-fourth week of the pregnancy.  On 13-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Jul-2020, Pregnancy test: positive (Positive) positive. In November 2020, Scan: normal (normal) normal. In January 2021, Blood test normal: normal (normal) normal. In January 2021, Gestational diabetes: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. Estimated date of conception: 07 Jul 2020 Previous pregnancy on 11 AP 2019 resulted into Sudden onset pre-eclampsia; no complications with infant.
This spontaneous report was received from a nurse via Pfizer and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions and concomitant medication was reported. On an unknown date, doses of PNEUMOVAX 23 were affected by the temperature excursion. Maximum temperature was 68 degrees Fahrenheit. The power in the refrigerator was out for 20 hours, which is the maximum amount of time the product was out of temperature range. It was unspecified if any patients received the affected PNEUMOVAX 23 but it could not be ruled out. Additional information has been requested.
Information has been received from a woman in a physician's office concerning a 14 month old pt who on an unspecified date was vaccinated with either a dose of MMRII or a dose of rubella virus vaccine live (2nd generation). The reporter was not sure which vaccine was administered. Subsequently, the pt developed a fever and rash. The pt sought unspecified medical attention. Additional information has been requested.
Red; Itchy; Rash; Swollen; Tender; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swollen), TENDERNESS (Tender), ERYTHEMA (Red), PRURITUS (Itchy) and RASH (Rash) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMIN [VITAMINS NOS], CLONAZEPAM, CALCIUM and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced SWELLING (Swollen) and TENDERNESS (Tender). On an unknown date, the patient experienced ERYTHEMA (Red), PRURITUS (Itchy) and RASH (Rash). At the time of the report, SWELLING (Swollen), TENDERNESS (Tender), ERYTHEMA (Red), PRURITUS (Itchy) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow up received and contain non significant information.
PATIENT RECEIVED ONE DOSE OF PFIZER IM INJECTION TO HER RIGHT DELTOID @ APPROXIMATELY 11:25 A.M. @ 11:30 A.M. PATIENT COMPLAINED OF A "SCRATCHY" THROAT WITHIN 5 MINUTES OF RECEIVING THE VACCINE. PATIENT DID NOT HAVE ANY DIFFICULTIES SWALLOWING OR BREATHING. PATIENT DID NOT HAVE ANY VISIBILE FACIAL EDEMA. PATIENT WAS PROVIDED WATER TO DRINK AND WAS ABLE TO SWALLOW WITHOUT ANY ISSUES. PATIENT WAS PROVIDED 12.5 MG LIQUID ORAL BENADRYL. PATIENT STATED HER SYMPTOMS RESOLVED WITHIN 15 MINUTES AFTER RECEIVING THE ORAL BENADRYL.
8/21/21: Patient presents with complaints of cough, sore throat, weakeness and fatigue for about a week. Tested positive for COVID on admission.  Diagnosed with: acute pharyngitis, acute renal failure, cough, pneumonia due to COVID-19, fatigue Note: Patient recieved J&J vaccine on 03/11/2021. 8/26/21: Patient discharged.
On 2/13/21, my left arm begin to feel itchy and a rash appeared.  The rash also appeared on my right arm, neck, back and stomach however it was worse on left arm.  It was extremely itchy and would burn after I scratched.  I tried using Benadryl, hydrocortisone  and it did not lessen the symptoms.  I contacted my Primary Physician on the evening of 2/14/21 and asked for treatment.  The Doctor called in a steroid. It is providing some relief and the itching has lessened.
Swelling of the upper arm, extremely sore in upper arm. Felt weak like a mild case of the flu. Had to leave the arm immobile for three days. Soreness diminished by fourth day but the swelling persisted for five days. When swelling diminished in the upper arm, the lower arm was swollen, especially around the elbow.
Information has been received from a licensed PRN concerning a female who in October, 2003, "couple of weeks ago" was vaccinated in the he arm with a dose of pneumococcal 23v polysaccharide and was evaluated at the office for a red, swollen and painful arm. Unspecified medical attention was sought. Subsequently, the symptoms resolved and the pt recovered. There was no product quality complaint involved. Follow up info received from an LPN indicated that the outcome is recovered. The reporter expressed concern about the particular lot of vaccine and requested a lot check on 1026M. The records of testing prior to release of this lot have been checked by QA and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. The reporter also mentioned that three other pts were vaccinated with a dose of pneumococcal 23v polysaccharide vaccine and experienced a similar rxn. Additional information is expected.
Pt was vaccinated 3/10/2021 at 11:00AM. By the afternoon, she experienced side effects: sweaty, chills, body aches, diarrhea, headache, fatigue symptoms.
took a rapid Covid test and it came back positive; took a rapid Covid test and it came back positive; sinus infection and it went a little down into his lungs; This is a spontaneous report from a contactable consumer (patient) or other non-healthcare professional. A 59-year-old male patient received BNT162B2 (COMIRNATY, Formulation: Solution for Injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date (age at vaccination: 59 year) as dose 2, single, dose 1 via an unspecified route of administration on an unspecified date (age at vaccination: 59 year) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient received Pfizer Covid-19 shots and experienced like he had a sinus infection and it went a little down into his lungs. Patient reported that he went on a bike ride and that usually makes his sinuses act up, he said he went and took a rapid Covid test and it came back positive. Patient reported that someone told him that you can test positive after receiving the Covid-19 vaccine. Patient asked is that true. Patient supposed to go camping then he got a sinus infection, in his nose, patient thought might should get tested. Patient went and got tested, one of the pharmacy tests, the rapid test, and it said he was positive for Covid. The patient underwent lab tests and procedures which included sars-cov-2 test: positive, on unspecified date, He went and got tested, one of the pharmacy tests, the rapid test, and it says he was positive for Covid. The clinical outcome of the events was unknown.  The lot number for the vaccine [BNT162B2], was not provided and will be requested during follow up. .
pt recv vax 10OCT95 & devel numbness & tingling in rt arm;also exp muscle weakness characterized by pain in back & chest being unable to stand on feet;
Angioedema; face and hand swelling; face and hand swelling; generalized hives and into mouth requiring ER visit; This is a initial spontaneous report processed with follow up from a contactable consumer (patient's mother). A contactable consumer reported for her son. A 33-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date was not reported) via an unspecified route of administration on an unspecified date as 2ND DOSE, SINGLE for Covid-19 immunization. The patient medical history was not reported. No prior history of allergic response to any medication or food. The patient concomitant medications were not reported. Patient received second dose of Pfizer vaccine 2 and half weeks ago. Within 48 hours the patient had experienced angioedema, face and hand swelling, generalized hives and into mouth requiring ER (emergency room) visit and ongoing high doses of steroids and antihistamines due to persistent symptoms. The patient has completed the untoward reaction form and sent it to the directed website but no response. Currently the patient has an appointment with PRIVACY 21May2021 out of desperation of what to do. Patient received treatment for the events. The patient underwent lab tests and procedures which included serum allergy test: negative on an unspecified date. The outcome of the events was still experiencing side effects.  Information about Lot/Batch number has been requested.
Not received 2nd dose yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 21 October 2022).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Not received 2nd dose yet).  The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 04-OCT-2023 The pharmacist stated that a patient received the first dose of Shingrix. It did not appear that the patient had yet received the 2nd dose as the Healthcare professional was looking for recommendations on how to proceed. The reporter consented to follow up via postal. The vaccine administration facility is the same as primary reporter for 1st dose. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
A non-serious spontaneous report of "we gave H1N1 vaccine to a six-month-old child" and cough has been received from a physician concerning a six-month-old male, subsequent to H1N1, Intranasal. The patient's past medical history included feeding problem as a newborn, whereby feedings took approximately one-hour each which had resolved. The patient had not taken any concomitant medication. On 26-Oct-2009, the patient received H1N1, Intranasal for an unknown indication. The patient had a cough for the past week. The patient had good reflex tone, lungs were clear bilaterally to auscultation; there was no respiratory distress, rectal temperature was 98.2, thus no necessary medical intervention was required. The outcome was unknown. Additional information was received on 12-Nov-2009 and incorporated into the narrative: cough has been added as new event term. The medical history has been added and new information incorporated into event description.
Felt odd the evening of 4/1/2021.  When i go up the next morning had a sensation of feeling off like when you stand up too quick and you feel of a little dizzy but not dizzy.  Has not gone away.  Having more headaches.  Vision is strange.  Almost magnified so I feel unbalanced. My doctor wanted me to get my eyes checked.  Went to my ophthalmologist to run tests.  Nothing had changed from my previous visit prior to taking the shot.  Sometimes it intensifies.  Has never gone away.  Makes me feel out of control.  I can't quiet my brain.  I have never been one to hum.  Now I hum constantly. I can't control it.
allergic reaction (redness, dermatitis, itching, eyes edematous, chest feels a little tight; occurred approx 5 hrs p/receiving 3rd dose of Hep b vax; tx Atarax;
17 yo female received MENVEO AM of 7/5/11. Around 6pm noticed reaction to left upper arm. Described as "itchy" and "painful". Exam - 6-7 cm of erythema, sl. warmth, sl. tenderness. Very sharply demarcated. Rx. OTC BENADRYL, BACTRIM DS 1 PO BID, topical steroid.
8x6 cm erythema, swelling, itching (L) deltoid- Inflammatory response? Allergic? R/O early Infections.
Gardasil was given on righ upper arm on 2/26/08.  Went to ER.  Started to have swelling, redness, pain on injection site.  Don't have date client went to ER.
Patient presented to emergency department around 7:00pm with signs and symptoms consistent with stoke. In the drive to the hospital, patient could not speak, move the right side of his body, and was drooling. Patient was immediately taken for a head CT and was diagnosed with a massive hemorrhagic stroke. The on call neurosurgeon wall called in the perform and emergency craniotomy.  Patient underwent craniotomy and neurosurgeon was unable to find source or cause of bleed. Patient was sent to ICU for recovery. Patient was on a ventilator and receiving hypertonic saline for brain swelling. Patient never regained mobility in right side of body or speech. Patient tried rehabilitation, but patient's brain continued to swell with increase neuro-cognitive decline. Neurosurgeon was unable to determine cause of recurring edema and patient was not a candidate for repeat surgery. Patient failed rehab qualifications due to repeat brain swelling  and was eventually placed in hospice care to pass.
This inmate was vaccinated initially on 3/25/2021, then again on 4/26/2021 and again on 5/11/2021. He has not had a reaction but received a third dose in error.